UM
Umang Mithal
About Umang Mithal
Data last updated:
Umang Mithal is a Director at Galaxy Oncology Associates Private Limited (since 2022), Director at Cosmos Cancer Tecmed Private Limited (since 2005) and Director at Vaidyanta Research India Private Limited (since 2014). The companies operate in Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹1.08 Cr; the largest is Galaxy Oncology Associates Private Limited at ₹1.08 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Galaxy Oncology Associates Private Limited U85110DL2006PTC154903 | Director | 08 Aug 2022 | 2006 | ₹1.08 Cr (FY 2024) | Active |
| Cosmos Cancer Tecmed Private Limited U85110DL2005PTC135469 | Director | 27 Apr 2005 | 2005 | ₹18,200 (FY 2025) | Active |
| Vaidyanta Research India Private Limited U85100DL2014PTC264829 | Director | 19 Mar 2014 | 2014 | ₹13,926 (FY 2025) | Active |
Board colleagues of Umang Mithal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sachin Kumar | 09839634 | Galaxy Oncology Associates Private Limited | Director |
| Sandeep Agarwal | 00808701 | Galaxy Oncology Associates Private Limited , Cosmos Cancer Tecmed Private Limited | Director |
| Nalini Mithal | 00993510 | Cosmos Cancer Tecmed Private Limited | Director |
| Pragati Agarwal | 01939715 | Cosmos Cancer Tecmed Private Limited | Director |
| Ajay Kumar Gupta | 01053059 | Vaidyanta Research India Private Limited | Director |
| Ashok Kumar Goel | 00090143 | Vaidyanta Research India Private Limited | Director |
| Nitin Goel | 00727152 | Vaidyanta Research India Private Limited | Director |
| Peeyush Goel | 00298374 | Vaidyanta Research India Private Limited | Director |
| Sagar Gupta | 06862510 | Vaidyanta Research India Private Limited | Director |
| Subhash Chandra Agarwal | 01254824 | Vaidyanta Research India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Umang Mithal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Umang Mithal
Umang Mithal currently holds 3 directorships: Galaxy Oncology Associates Private Limited (Director, since 08 Aug 2022, revenue ₹1.08 Cr (FY 2024)); Cosmos Cancer Tecmed Private Limited (Director, since 27 Apr 2005, revenue ₹18,200 (FY 2025)); Vaidyanta Research India Private Limited (Director, since 19 Mar 2014, revenue ₹13,926 (FY 2025)).
Umang Mithal was first appointed on 27 Apr 2005 as Director at Cosmos Cancer Tecmed Private Limited. The most recent appointment on record is 08 Aug 2022 at Galaxy Oncology Associates Private Limited.
The 3 current companies of Umang Mithal that report revenue have a combined latest revenue of ₹1.08 Cr: Galaxy Oncology Associates Private Limited ₹1.08 Cr (FY 2024); Cosmos Cancer Tecmed Private Limited ₹18,200 (FY 2025); Vaidyanta Research India Private Limited ₹13,926 (FY 2025).
The current boards of Umang Mithal's companies include Sachin Kumar (Galaxy Oncology Associates Private Limited), Sandeep Agarwal (Galaxy Oncology Associates Private Limited), Nalini Mithal (Cosmos Cancer Tecmed Private Limited), Pragati Agarwal (Cosmos Cancer Tecmed Private Limited), Ajay Kumar Gupta (Vaidyanta Research India Private Limited), Ashok Kumar Goel (Vaidyanta Research India Private Limited), among others.